[Oncogenic and tumour suppressor microRNAs]

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• MicroRNAs (miRNAs) are key regulators of gene expression, impacting protein translation and mRNA degradation.
• Dysregulated miRNA expression is implicated in various cancers, suggesting roles as oncogenes or tumor suppressors.
• The miR-17-92 cluster has demonstrated oncogenic properties in Myc-induced B cell lymphoma models.

Purpose of the Study:

• To elucidate the role of microRNAs in cancer development and gene regulation.
• To investigate the oncogenic mechanisms of the miR-17-92 cluster.
• To understand how c-Myc proto-oncogene misregulation contributes to tumorigenesis via miRNA control.

Main Methods:

• Analysis of miRNA expression patterns in cancer.
• Identification of miRNA targets involved in apoptosis and cell proliferation.
• Investigation of the regulatory relationship between c-Myc and specific microRNAs.

Main Results:

• The miR-17-92 cluster targets mRNAs encoding proteins that inhibit apoptosis and promote proliferation, contributing to its oncogenic role.
• Tumor suppressor miRNAs, such as let-7, target oncogenes and are often downregulated in cancers.
• c-Myc was found to control the expression of several microRNAs, linking its proto-oncogenic activity to miRNA dysregulation.

Conclusions:

• MicroRNAs play critical roles in tumorigenesis, acting as either oncogenes or tumor suppressors.
• The miR-17-92 cluster promotes cancer progression through specific gene targeting.
• c-Myc's influence on miRNA expression provides a novel mechanism for its oncogenic function.